Hantavirus infection

This page is about clinical aspects of the disease.  For microbiologic aspects of the causative organism(s), see Hantavirus.

For patient information, click here

Hantavirus infection Microchapters
Home
Patient Information Hantavirus cardiopulmonary syndrome (HCPS) (patient information) Hemorrhagic fever with renal syndrome (HFRS) (patient information)
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hantavirus infection from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT Scan
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future Investigational Therapies
Case Studies
Case #1
Hantavirus infection On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hantavirus infection All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hantavirus infection
CDC on Hantavirus infection
Hantavirus infection in the news
Blogs on Hantavirus infection
Directions to Hospitals Treating Hantavirus pulmonary syndrome
Risk calculators and risk factors for Hantavirus infection

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2] Usama Talib, BSc, MD [3] Seyedmahdi Pahlavani, M.D. [4] Furqan M M. M.B.B.S[5]

Synonyms and keywords: Sin nombre virus infection; Hantavirus cardiopulmonary syndrome (HCPS); Nephropathia epidemica (NE); Hemorrhagic fever with renal syndrome (HFRS)

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention |Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

Acknowledgements

The content on this page was first contributed by: C. Michael Gibson, M.S., M.D. List of contributors: Pilar Almonacid